Mode
Text Size
Log in / Sign up

Maternal APOL1 risk alleles show no independent association with preeclampsia risk in multi-ethnic studyStudy finds no link between maternal APOL1 gene variants and preeclampsia risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that maternal APOL1 genotype alone shows no independent association with preeclampsia risk.

This nested case-control study examined 5210 pregnant women, including 745 preeclampsia cases and 949 controls of Black self-reported ethnicity, plus 1385 cases and 2131 controls of White self-reported ethnicity. Researchers compared women with two APOL1 G1/G2 risk alleles against those with zero or one risk allele to assess preeclampsia risk.

For all women combined, 17.9% of cases (133/745) and 17.7% of controls (168/949) carried two risk alleles, showing no significant association (OR 1.00, 95% CI 0.76-1.29, p=0.972). In Black women specifically, the adjusted OR was 0.94 (95% CI 0.61-1.25, p=0.673), and in those with pan-African genetically-determined ancestry, the adjusted OR was 1.00 (95% CI 0.76-1.32). Secondary outcomes including early preeclampsia, recurrent preeclampsia, birthweight centiles, and gestational age at delivery also showed no associations.

Safety and tolerability data were not reported. The study represents the largest genetic investigation of maternal APOL1 and preeclampsia in women of Black ethnicity. Key limitations include unexamined fetal genotypes and gene-environment interactions, and the authors note that unadjusted associations reflected West African genetic ancestry rather than direct causation. For clinical practice, these findings suggest maternal APOL1 genotype alone may not be useful for preeclampsia risk stratification.

Researchers conducted a large genetic study to see if specific variants in a gene called APOL1, carried by the mother, were linked to a higher risk of developing preeclampsia during pregnancy. Preeclampsia is a serious pregnancy complication involving high blood pressure. The study included over 5,000 pregnant women who self-reported as Black or White, including 745 Black women who had preeclampsia.

The main finding was that having two of these APOL1 risk variants did not increase a woman's chance of getting preeclampsia. This was true for women of both Black and White self-reported ethnicity. The study also found no link between these gene variants and other related outcomes, like early or recurrent preeclampsia, baby's birth weight, or gestational age at delivery.

This is the largest study so far to look at this specific question in women of Black ethnicity. The researchers note that their analysis focused only on the mother's genes. They did not look at the baby's genes or how genes might interact with environmental factors like diet or stress. Because of this, the results do not rule out other possible genetic or non-genetic causes of preeclampsia.

For now, this study provides reassuring evidence that these particular maternal APOL1 gene variants are not a major independent risk factor for preeclampsia. It helps narrow down the search for genetic causes, but understanding all the factors that lead to this condition will require more research.

What this means for you:
A large study found no link between specific maternal gene variants and preeclampsia risk, but more research is needed.

Study Details

Study typeCase control
EvidenceLevel 4
PublishedMar 2026
View Original Abstract ↓
BackgroundAPOL1 risk alleles are prevalent in individuals of West African ancestry and associated with increased risk of kidney disease. Although preeclampsia disproportionately affects women of Black ethnic backgrounds, evidence linking APOL1 alleles to preeclampsia remains conflicting. ObjectivesThe purpose of this study was to explore whether maternal APOL1 alleles contribute to preeclampsia risk and associated adverse pregnancy outcomes. Study designWe conducted a nested case-control study of 5210 pregnant women, including 745 preeclampsia cases and 949 controls of Black self-reported ethnicity, 1385 preeclampsia cases and 2131 controls of White self-reported ethnicity. APOL1 G1 and G2 risk alleles were directly genotyped on the Illumina Infinium(R) Global Screening Array. Associations with preeclampsia, early preeclampsia, recurrent preeclampsia, birthweight centiles and gestational age at delivery were examined using regression models assuming a recessive mode of inheritance with adjustment for established risk factors and stratification by self-reported ethnicity and genetically-determined ancestry. ResultsPresence of APOL1 risk alleles was almost exclusively observed in women of Black self-reported ethnicity. 168/949 controls (17.7%) and 133/745 cases (17.9%) carried two APOL1 risk alleles, and these women did not have a significantly increased risk of preeclampsia compared to those with zero or one APOL1 risk alleles in adjusted analyses (OR 1.00, 95% CI 0.76-1.29, p=0.972). When restricting analysis to women of Black self-reported ethnicity only, no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 0.94, 95% CI 0.61-1.25, p=0.673). When restricting analysis to women of pan-African genetically-determined ancestry only, also no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 1.00, 95% CI 0.76-1.32). No associations were found between number of APOL1 risk alleles and early preeclampsia, recurrent preeclampsia, birthweight centile or gestational age at delivery after adjustment for established risk factors and stratification by self-reported ethnicity or genetically-determined ancestry. ConclusionsMaternal APOL1 risk alleles do not independently influence preeclampsia risk or related adverse outcomes in a multi-ethnic pregnancy study. Future studies should examine whether fetal APOL1 genotypes, alone or in interaction with maternal genotypes, contribute to preeclampsia risk. At a GlanceA. Why was this study conducted?O_LIAPOL1 risk alleles are prevalent in West African ancestry populations and associated with kidney disease C_LIO_LIPreeclampsia disproportionately affects women of Black ethnicity C_LIO_LIPrevious studies showed conflicting evidence linking maternal APOL1 alleles to preeclampsia risk C_LI B. What are the key findings?O_LIIn 5,210 multi-ethnic women, maternal APOL1 risk alleles showed no independent association with preeclampsia or related adverse outcomes C_LIO_LIAssociations in unadjusted analyses reflected West African genetic ancestry rather than direct causation C_LI C. What does this study add to what is already known?O_LILargest genetic study of maternal APOL1 and preeclampsia in women of Black ethnicity (745 cases) C_LIO_LIDemonstrates APOL1 alleles serve as ancestry markers rather than causal variants C_LIO_LIHighlights need to examine fetal genotypes and gene-environment interactions C_LI
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.